Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.
about
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@ast
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@en
type
label
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@ast
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@en
prefLabel
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@ast
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@en
P2093
P2860
P50
P1476
Evaluation of chromosome 6p22 ...... dy of BRCA2 mutation carriers.
@en
P2093
Andrew K Godwin
CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella (CONSIT Team)
Christian F Singer
Csilla I Szabo
Evgeny Imyanitov
German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)
HEreditary Breast and Ovarian Cancer Group Netherlands (HEBON)
Kristen N Stevens
Laima Tihomirova
Lara Sucheston
P2860
P2888
P304
P356
10.1007/S10549-012-2255-6
P407
P50
P577
2012-09-26T00:00:00Z